Fibromyalgia incidence among patients with hepatitis B infection

Basit Öğe Kaydı
dc.contributor.authorYazmalar, Levent
dc.contributor.authorDeveci, Ozcan
dc.contributor.authorBatmaz, Ibrahim
dc.contributor.authorIpek, Davut
dc.contributor.authorCelepkolu, Tahsin
dc.contributor.authorAlpayci, Mahmut
dc.contributor.authorHattapoglu, Erkam
dc.date.accessioned2024-04-24T17:11:24Z
dc.date.available2024-04-24T17:11:24Z
dc.date.issued2016
dc.departmentDicle Üniversitesien_US
dc.description.abstractAim: The purpose of our investigation was to evaluate the incidence of fibromyalgia syndrome (FMS) and identify FMS-related clinical symptoms in hepatitis B virus (HBV) patients. Methods: One hundred and eighteen HBV surface antigen (HbsAg)-positive patients (40 with chronic active hepatitis B, 40 hepatitis B carriers and 38, all of whom had been antiretroviral-treated for at least 3 months) were included in this study. In addition, 60 age- and gender-matched HbsAg-negative healthy controls were included in the study. Results: There was no significant difference in age, gender or body mass index (BMI) between the two groups (P > 0.05). Serum aspartate aminotransferase and alanine aminotransferase levels were significantly higher in HBV patients relative to the control group (P < 0.05). The incidence of FMS, widespread body pain, fatigue, sleep disturbance, anxiety, morning stiffness, arthralgia was significantly greater among HBV patients relative to the control group. Additionally, the mean tender point counts and the visual analog scale values were significantly higher among the HBV patients (P < 0.05). Conclusions: The results of the present study demonstrate that FMS incidence is greater among HBV patients relative to control subjects. However, there were no differences in FMS incidence among the subgroups of HBV diagnoses.en_US
dc.identifier.doi10.1111/1756-185X.12593
dc.identifier.endpage643en_US
dc.identifier.issn1756-1841
dc.identifier.issn1756-185X
dc.identifier.issue7en_US
dc.identifier.pmid26133007
dc.identifier.scopus2-s2.0-84983242535
dc.identifier.scopusqualityQ3
dc.identifier.startpage637en_US
dc.identifier.urihttps://doi.org/10.1111/1756-185X.12593
dc.identifier.urihttps://hdl.handle.net/11468/17478
dc.identifier.volume19en_US
dc.identifier.wosWOS:000383531000002
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoenen_US
dc.publisherWileyen_US
dc.relation.ispartofInternational Journal of Rheumatic Diseases
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectFibromyalgia Syndromeen_US
dc.subjectHepatitis Ben_US
dc.subjectPainen_US
dc.titleFibromyalgia incidence among patients with hepatitis B infectionen_US
dc.titleFibromyalgia incidence among patients with hepatitis B infection
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu